Five Prime Therapeutics, Inc.
FPRX
FPRX was delisted on the 15th of April, 2021.
94 hedge funds and large institutions have $122M invested in Five Prime Therapeutics, Inc. in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 34 increasing their positions, 37 reducing their positions, and 18 closing their positions.
17% more capital invested
Capital invested by funds: $105M → $122M (+$17.5M)
8% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 37
9% less funds holding
Funds holding: 103 → 94 (-9)
50% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 18
75% less call options, than puts
Call options by funds: $4K | Put options by funds: $16K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$15.9M |
| 2 |
Renaissance Technologies
New York
|
+$1.69M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.24M |
| 4 |
Two Sigma Investments
New York
|
+$1.16M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$951K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.62M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.96M |
| 3 |
Man Group
London,
United Kingdom
|
-$3.13M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$2M |
| 5 |
BlackRock
New York
|
-$1.67M |
FPRX Hedge Fund Activity: Q4 2019 in Review
94 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q4 2019, worth a combined $122M — up 17% from $105M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of FPRX and 9 opened new positions — a net loss of 9 holders — while 37 trimmed existing stakes and 34 added.
The largest buyer was BVF Inc, adding an estimated $15.9M. The largest seller was Wellington Management Group, cutting an estimated $4.62M.
- 94 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q4 2019, down from 103 in Q3 2019.
- Funds reported $122M of Five Prime Therapeutics, Inc. stock for Q4 2019, up 17% quarter-over-quarter.
- 9 funds opened new Five Prime Therapeutics, Inc. positions in Q4 2019 and 18 closed out, a net change of -9 holders.
- The largest Five Prime Therapeutics, Inc. buyer in Q4 2019 was BVF Inc, an estimated $15.9M added.
- The largest Five Prime Therapeutics, Inc. seller in Q4 2019 was Wellington Management Group, an estimated $4.62M sold.
Based on aggregated 13F filings for Q4 2019.